Let’s Talk CMV and Beyond 2026
We invite you to engaging sessions covering key updates on the International Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation, ECILs guidelines and patient cases

Join us for an interactive Nordic meeting.
We invite you to an engaging session
covering the topic: ”ECIL-10 CMV
guidelines and what has happened since then”
This is a unique opportunity to engage with
leading experts, gain valuable insights, and
participate in dynamic discussions.

Time: March 18th, 2026, 16.30 -17.30 (CET), 17.30 -18.30 Finnish time
Place: Webinar
AGENDA 18th of March

SPEAKER

Per Ljungman, Prof. Emeritus, Karolinska Institutet
Marietta Nygaard, Dr, department of hematology, Rigshospitalet Copenhagen

REGISTER 

For more information and registration for
webinar on 18th of March, please click
here Please register before 13th of March 2026

Join us for an interactive Nordic meeting.
We invite you to an engaging session
covering key updates on the ”Fourth
International Consensus Guidelines on the
Management of Cytomegalovirus in Solid
Organ Transplantation”

This is a unique opportunity to engage with
leading experts, gain valuable
insights, and participate in dynamic
discussions.

Time: March 25th, 2026, 16.30 -17.30 (CET), 17.30 -18.30 Finnish time
Place: Webinar

AGENDA 25th of March

SPEAKER

Ilkka Helanterä, Prof. MD, PhD, Adj. Transplantation and Liver Surgery, Helsinki University Hospital
Susanne Dam Poulsen,Prof. Infection specialist, Rigshospitalet Copenhagen

REGISTER 

For more information and registration for
webinar on 25th of March, please click
here  Please register before 21st of March 2026

VÄLKOMMEN

Emma Silfverswärd
Brand and Customer Manager
M: +46 705 216 373
emma.silfversward@takeda.com

Birgitta Trangius
Key Account Manager
Immunology
M: +46 70-552 13 55
birgitta.trangius@takeda.com

Christina Kristensson
Key Account Manager
Immunology
M: +46 73-840 82 48
christina.kristensson@takeda.com

This meeting is initiated, organized and funded by Takeda. Takeda covers, in accordance with LER, speaker fees
within the framework of the meeting. Participation in the meeting is free of
charge. According to the agreement on information and education between the Swedish
Association of the Pharmaceutical Industry (Läkemedelsindustriföreningen) and SKL, this
invitation to the training has been sent as a copy to your operations manager as well as
the relevant pharmaceutical committee. The mailing has been sent using information from
the Healthcare Address Register (HSAR) by Takeda Pharma AB, which is affiliated with the
HSAR Data Protection Program. Further information about address details and
registration can be obtained via www.hsar.se or from IQVIA, +46 8-555 214 20.
C-ANPROM/SE/CMV/0007 02/2026